AI Article Synopsis
- HPV vaccination significantly lowers the risk of cervical cancer and its early stages, especially when given before a person becomes sexually active.
- This review evaluates the recommendation for the nonavalent HPV vaccine for women who have already received the bi- or quadrivalent vaccines.
- It also considers whether the vaccine should be advised for women with a history of condylomas or dysplasia in the vulva, vagina, or cervix.
Article Abstract
HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
hpv vaccine
8
[hpv vaccination
4
vaccination women]
4
women] hpv
4
hpv vaccination
4
vaccination associated
4
associated reduced
4
reduced risk
4
risk cervical
4
cervical cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!